(5S)-3-aryl-5-(1-piperidinylmethyl)-2-oxazolidinones, a new class of potential neuroleptics with a high affinity for sigma receptors
- 1 January 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (2) , 165-170
- https://doi.org/10.1016/s0960-894x(01)80443-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disordersLife Sciences, 1990
- Rimcazole (BW234U) in the maintenance treatment of outpatients with schizophreniaDrug Development Research, 1989
- Novel antipsychotic drugs share high affinity for σ receptorsEuropean Journal of Pharmacology, 1988
- Potential antipsychotic BMY 14802 selectively binds to sigma sitesDrug Development Research, 1987
- Rimcazole (BW 234U), a novel antipsychotic agent whose mechanism of action cannot be explained by a direct blockade of postsynaptic dopaminergic receptors in brainDrug Development Research, 1986
- The dopamine hypothesis of schizophrenia: focus on the dopamine receptorAmerican Journal of Psychiatry, 1976